ASCRS 2024: A retrospective study shows iStent’s impact on medication burden in surgical and non-surgical patient groups
At this year’s ASCRS meeting Rom Kandavel, MD, of Colvard-Kandavel Eye Center in Los Angeles, California discussed the paper he presented at the meeting, which focused on IOP lowering and medication burden for patients who received the iStent inject.